Two Cases of Hand-Foot Syndrome Induced by Sunitinib / 대한피부과학회지
Korean Journal of Dermatology
;
: 1236-1239, 2008.
Article
in Korean
| WPRIM
| ID: wpr-40579
ABSTRACT
Sunitinib (SU11248) is a novel orally administered small molecule that inhibits multiple receptor tyrosine kinases so that can block tumor growth and angiogenesis. It was approved on 2006, for the treatment of advanced renal cell carcinoma and gastrointestinal stromal tumor. Various cutaneous adverse reactions induced by sunitinib have been reported, including hand-foot syndrome. We report two cases of hand-foot syndrome induced by sunitinib for treatment of advanced renal cell carcinoma.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Phosphotransferases
/
Pyrroles
/
Tyrosine
/
Carcinoma, Renal Cell
/
Gastrointestinal Stromal Tumors
/
Hand-Foot Syndrome
/
Indoles
Language:
Korean
Journal:
Korean Journal of Dermatology
Year:
2008
Type:
Article
Similar
MEDLINE
...
LILACS
LIS